Thermo Fisher Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Thermo Fisher Scientific has a total shareholder equity of $47.5B and total debt of $35.2B, which brings its debt-to-equity ratio to 74.1%. Its total assets and total liabilities are $98.5B and $51.0B respectively. Thermo Fisher Scientific's EBIT is $7.4B making its interest coverage ratio 22.4. It has cash and short-term investments of $8.8B.
Key information
74.1%
Debt to equity ratio
US$35.22b
Debt
| Interest coverage ratio | 22.4x |
| Cash | US$8.82b |
| Equity | US$47.54b |
| Total liabilities | US$50.96b |
| Total assets | US$98.50b |
Recent financial health updates
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Jun 18
We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Dec 11Recent updates
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings
Aug 16Thermo Fisher Scientific: Microscopic Signs Of Growth Emerging
Jul 25A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Jul 11Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Jun 18Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends
Jun 07Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)
Apr 30Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 27Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching
Apr 24Thermo Fisher Scientific: Too Hot To Handle
Apr 15Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)
Apr 02We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Thermo Fisher's Bright Future Makes It A Great Buy On Weakness
Feb 06Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results
Feb 02Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics
Jan 16Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'
Jan 06Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?
Dec 29Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?
Dec 11Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.
Dec 02Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate
Nov 07My Family Is Buying A Lot More Thermo Fisher Stock
Oct 31Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness
Sep 28Financial Position Analysis
Short Term Liabilities: TMO's short term assets ($25.5B) exceed its short term liabilities ($14.8B).
Long Term Liabilities: TMO's short term assets ($25.5B) do not cover its long term liabilities ($36.2B).
Debt to Equity History and Analysis
Debt Level: TMO's net debt to equity ratio (55.5%) is considered high.
Reducing Debt: TMO's debt to equity ratio has increased from 66.4% to 74.1% over the past 5 years.
Debt Coverage: TMO's debt is well covered by operating cash flow (26.5%).
Interest Coverage: TMO's interest payments on its debt are well covered by EBIT (22.4x coverage).